Myriad Genetics has submitted a supplementary premarket approval application to FDA for its myChoice CDx test to help identify women with advanced ovarian cancer who are potential candidates for maintenance therapy with Lynparza (olaparib) in combination with bevacizumab.
Patients who underwent a stem cell transplant and received the Triplex vaccine to prevent a type of herpes virus, cytomegalovirus, from duplicating out of control were 50% less likely to develop health complications related to the virus than patients who did not take Triplex, according to a City of Hope-led study published today in Annals of Internal Medicine.
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center found that treating soft tissue sarcoma with radiation over a significantly shorter period of time is safe, and likely just as effective, as a much longer conventional course of treatment.
The phase III KEYNOTE-355 trial investigating Keytruda in combination with chemotherapy met one of its dual primary endpoints of progression-free survival in patients with metastatic triple-negative breast cancer whose tumors expressed PD-L1 (Combined Positive Score [CPS] ≥10).
The phase III PROSPER trial, which evaluated Xtandi (enzalutamide) plus androgen deprivation therapy versus placebo plus ADT in men with non-metastatic castration-resistant prostate cancer, demonstrated a statistically significant improvement in overall survival in patients with nmCRPC who were treated with Xtandi plus ADT.
A team of scientists at the Keck School of Medicine of USC have found people who vape exhibit similar chemical modifications in their overall genome and in parts of their DNA as people who smoke cigarettes.
A program at Ohio State is trying to make use of cancer drugs that would otherwise go to waste.
The Neuroendocrine Tumor Research Foundation provided $3.5 million in neuroendocrine tumor research grants to 12 projects to find more precise treatments for the cancer.
Jeff Boyd was named vice president, chief scientific officer and director of the Cancer Institute's Center for Genomic Medicine at The Northwell Health Cancer Institute. He will also hold an appointment as professor and member of the Cold Spring Harbor Laboratory Cancer Center.
Colleen McBride was named associate director for community outreach and engagement at Winship Cancer Institute of Emory University.
